Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Telescope Innovations's FCF Margin % or its related term are showing as below:
FRA:J4U'
s FCF Margin % Range Over the Past 10 Years
Min: -432.77 Med: -38.79 Max: -0.47
Current: -85.5
During the past 7 years, the highest FCF Margin % of Telescope Innovations was -0.47%. The lowest was -432.77%. And the median was -38.79%.
FRA:J4U's FCF Margin % is ranked worse than 50.42% of 950
companies
in the Biotechnology industry
Industry Median: -81.28
vs FRA:J4U: -85.50
Telescope Innovations FCF Margin % Related Terms
Telescope Innovations FCF Margin % Historical Data
* Premium members only.
The historical data trend for Telescope Innovations's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:J4U vs VRTX, REGN, ALNY: FCF Margin % Comparison
For the Biotechnology subindustry, Telescope Innovations's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Telescope Innovations FCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Telescope Innovations's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Telescope Innovations's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Telescope Innovations (FRA:J4U) has a FCF Margin % of -107.99% as of May. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Telescope Innovations and its competitors. According to the industry distribution chart, Telescope Innovations ranks #479 out of 950 companies in the Biotechnology industry, placing it in the top 50.4%.
Is Telescope Innovations' FCF Margin % too high?
Telescope Innovations' current FCF Margin % is -107.99%. Based on the distribution chart, Telescope Innovations ranks #479 out of 950 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Telescope Innovations has a GF Score™ of 20/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Telescope Innovations' FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Telescope Innovations ranks #479 out of 950 companies for FCF Margin %. This places Telescope Innovations in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Telescope Innovations and its competitors. Telescope Innovations's current FCF Margin % is -107.99%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Telescope Innovations stock overvalued right now?
Based on GuruFocus' analysis, Telescope Innovations (FRA:J4U) is currently considered Modestly Overvalued. The stock's GF Value™ is €0.32, compared to a current price of €0.37 — trading 15% above its estimated fair value. The current FCF Margin % is -107.99%. Telescope Innovations' overall GF Score™ is 20/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Telescope Innovations (FRA:J4U), the current FCF Margin % is -107.99% as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Telescope Innovations (FRA:J4U) Overvalued in 2026?
Based on GuruFocus' analysis, Telescope Innovations stock appears to be overvalued.
The current stock price of €0.37 is trading 15% above its estimated GF Value™ of €0.32.
GuruFocus considers Telescope Innovations to be Modestly Overvalued.
Key valuation signals for FRA:J4U:
FCF Margin %: -107.99%
GF Value™: €0.32 vs. price of €0.37 (15% above fair value)
No single metric tells the full story. See the FRA:J4U stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Telescope Innovations Corp is a technology company focused on development as a Contract Research Organization (CRO) to develop intellectual property, provide contract research, and build automation products, and operates as a chemical technology company developing scalable manufacturing processes and tools for the pharmaceutical and chemical industry. Its flagship product is the DirectInject-LC system. The Company operates in a single operating segment and generates revenue from three streams: contract research services, grant income, and the sale of automation products, with the majority of revenue derived from automation product sales from customer contracts. It operates in Canada, the United States, Europe, and Asia, with the majority of revenue coming from the United States.
20GF Score
Get the complete analysis for FRA:J4U
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:J4U has been successfully added to your 
